共 116 条
[1]
Barnett K(2012)Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study Lancet 380 37-43
[2]
Mercer SW(2004)Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med 164 1957-1959
[3]
Norbury M(2005)Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender Ther Clin Risk Manag 1 39-48
[4]
Watt G(2010)Inappropriate prescribing predicts adverse drug events in older adults Ann Pharmacother 44 957-963
[5]
Wyke S(2010)Length of stay for older adults residing in nursing homes at the end of life J Am Geriatr Soc 58 1701-1706
[6]
Guthrie B(2012)Polypharmacy in nursing home in Europe: results from the SHELTER study J Gerontol A Biol Sci Med Sci 67 698-704
[7]
Gurwitz JH(2020)Deprescribing in Older People Approaching End of Life: A Randomized Controlled Trial Using STOPPFrail Criteria J Am Geriatr Soc 68 762-769
[8]
Koh Y(2019)Associations Between Polypharmacy, Symptom Burden, and Quality of Life in Patients with Advanced Life-Limiting Illness J Gen Intern Med 34 559-566
[9]
Kutty FB(2021)Medication Management in Frail Older People: Consensus Principles for Clinical Practice, Research, and Education J Am Med Dir Assoc 22 43-49
[10]
Li SC(2017)STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation Age Ageing 46 600-607